Hyper IgE Syndrome
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old (NCT04897113) | National Medical Research Center for Rehabilitation and Balneology | 2021-05-12 |
| Omalizumab to Treat Hyper-IgE (Job's) Syndrome (NCT00260702) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-24 |
Track Hyper IgE Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.